Clinical Trial Update: Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing optimal antiplatelet therapy after left atrial appendage closure in atrial fibrillation patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: National Institute of Cardiology, Warsaw, Poland | Conditions: Atrial Fibrillation | Phase 4 | Status: RECRUITING